Healthcare Services

Global Gastroesophageal Reflux Disease (GERD) Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Gastroesophageal Reflux Disease (GERD) Market Across 2026–2030?

The gastroesophageal reflux disease (gerd) market size has demonstrated steady growth in recent years. It is forecast to increase from $5.33 billion in 2025 to $5.46 billion in 2026, with a compound annual growth rate (CAGR) of 2.3%. The expansion observed historically can be attributed to the widespread use of antacids and h2 blockers, rising obesity prevalence, high consumption of processed foods, increased clinical diagnosis rates, and the availability of generic ppis.

The market for gastroesophageal reflux disease (gerd) is projected to experience consistent expansion over the upcoming years. This market is predicted to reach $6.2 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.3%. Factors contributing to this growth during the projection period include an increase in minimally invasive reflux procedures, a need for sustained symptom management, advancements in endoscopic device technology, an expanding elderly demographic, and heightened patient understanding. Key trends anticipated during the forecast timeframe encompass a greater long-term reliance on proton pump inhibitors, broader acceptance of minimally invasive gerd interventions, increasing recognition of lifestyle-oriented disease control, a wider array of endoscopic treatment choices, and enhanced diagnosis rates due to better screening methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp

What Drivers Are Shaping The Future Growth Of The Gastroesophageal Reflux Disease (GERD) Market?

The increasing occurrence of esophageal ailments is anticipated to drive the expansion of the **gastroesophageal reflux disease (GERD)** market in the future. Esophageal diseases are medical conditions that impact the esophagus, a muscular channel connecting the mouth to the stomach. Addressing esophageal diseases aims to mitigate symptoms, elevate quality of life, and avert complications, ultimately fostering better overall health and well-being for individuals affected by **gastroesophageal reflux disease**. For example, in **January 2023**, the American Cancer Society, a professional organization located in the **US**, stated that around **21,560** new cases of esophageal cancer are identified annually in the **United States**, with **16,120** deaths resulting from esophageal cancer. Hence, the rising prevalence of esophageal diseases is a key factor propelling the growth of the **gastroesophageal reflux disease (GERD)** market.

What Segmentation Levels Are Considered In The Gastroesophageal Reflux Disease (GERD) Market?

The gastroesophageal reflux disease (gerd) market covered in this report is segmented –

1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist

2) By Procedure: Invasive, Minimally Invasive

3) By End-Users: Hospital, Homecare, Specialty Clinics

Subsegments:

1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide

2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole

3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine

4) By Prokinetic Agents: Metoclopramide, Domperidone

5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol

Which Market Trends Are Creating New Opportunities In The Gastroesophageal Reflux Disease (GERD) Market?

Leading companies in the gastroesophageal reflux disease (GERD) market are prioritizing the introduction of innovative treatment devices to maintain their competitive standing. A notable instance occurred in April 2023 when Laborie Medical Technologies, a US-based medical technology company, unveiled its new alpHaONE wireless pH-capsule reflux testing diagnostic system, specifically engineered for diagnosing gastroesophageal reflux disease (GERD). This system is capable of providing up to 96 hours of monitoring data and boasts a compact design, featuring enlarged buttons and a fail-safe capsule delivery system. Furthermore, it integrates a software application that includes a virtual instruction program and user-customizable symptom buttons, collectively aiming to improve the user experience.

Which Leading Firms Are Contributing To The Growth Of The Gastroesophageal Reflux Disease (GERD) Market?

Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.

Read the full gastroesophageal reflux disease (gerd) market report here:

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report

Which Geographic Regions Are Influencing Demand In The Gastroesophageal Reflux Disease (GERD) Market?

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease (gerd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastroesophageal Reflux Disease (GERD) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp

Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2026, By The Business Research Company

Gastric Cancer Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Esophageal Cancer Global Market Report

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Gastroparesis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795